Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
Clinical trial NCT03738956 · UNKNOWN
Trial details
- NCT number
- NCT03738956
- Sponsor
- Globe Pharmaceuticals Limited
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2018-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.